Endoscopic and clinical follow-up of step-up and top-down Infliximab therapy in Crohn's disease

被引：0
|
作者：
Lv Sucong [1 ]
Chen Baili [1 ]
Xiao Yinglian [1 ]
Chao Kang [1 ]
He Yao [1 ]
Zeng Zhirong [1 ]
Gao Xiang [1 ]
Hu Pinjin [1 ]
Chen Minhu [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
Crohn's disease; Infliximab; Follow-up study;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：369 / 369
页数：1
相关论文
共 50 条
  • [31] Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up
    Devlin, Shane M.
    Panaccione, Remo
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (04) : 577 - +
  • [32] Long-term outcomes of top-down versus step-up treatment in newly diagnosed Crohn's disease: final data
    Hoekman, D.
    Stibbe, J.
    Baert, F.
    Caenepeel, P.
    Vergauwe, P.
    de Vos, M.
    van Bodegraven, A.
    Vermeire, S.
    D'Haens, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S56 - S57
  • [33] Effect of infliximab 'Top-down' therapy on weight gain in pediatric Crohn's disease
    Kim, Mi Jin
    Lee, Woo Yong
    Choi, Kyong Eun
    Choe, Yon Ho
    [J]. INDIAN PEDIATRICS, 2012, 49 (12) : 979 - 982
  • [34] Effect of infliximab ‘Top-down’ therapy on weight gain in pediatric Crohn’s disease
    Mi Jin Kim
    Woo Yong Lee
    Kyong Eun Choi
    Yon Ho Choe
    [J]. Indian Pediatrics, 2012, 49 : 979 - 982
  • [35] Effect of Infliximab 'Top-down' Therapy on Weight Gain in Pediatric Crohn's Disease
    Agarwal, Jaya
    [J]. INDIAN PEDIATRICS, 2013, 50 (06) : 615 - 616
  • [36] Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn’s disease
    Monia Marchetti
    Nicola L. Liberato
    Antonio Di Sabatino
    Gino R. Corazza
    [J]. The European Journal of Health Economics, 2013, 14 : 853 - 861
  • [37] Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease
    Marchetti, Monia
    Liberato, Nicola L.
    Di Sabatino, Antonio
    Corazza, Gino R.
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (06): : 853 - 861
  • [38] Infliximab: The Benefit for Refractory Crohn Disease and Top-down Induction Therapy in Severe Crohn Disease
    Lee, Jee Hyun
    Lee, Hae Jeong
    Park, Sung Eun
    Choe, Yon Ho
    [J]. PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2008, 11 (01) : 28 - 35
  • [39] COST-EFFECTIVENESS OF TOP-DOWN VERSUS STEP-UP STRATEGIES IN PATIENTS WITH NEWLY DIAGNOSED ACTIVE LUMINAL CROHN'S DISEASE (CD)
    Marchetti, M.
    Di Sabatino, A.
    Liberato, L.
    Guerci, M.
    Corazza, G. R.
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 : S133 - S133
  • [40] A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): Top-down versus step-up strategies.
    Hommes, D
    Baert, F
    van Assche, G
    Caenepeel, P
    Vergauwe, P
    Tuynman, H
    De Vos, M
    van Deventer, S
    Stitt, L
    Rutgeerts, P
    Donner, A
    Feagan, B
    D'Haens, G
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A577 - A577
12345